These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29067086)

  • 1. The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs.
    Yu L; Yuan M; Wang L
    Pak J Med Sci; 2017; 33(4):1022-1028. PubMed ID: 29067086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
    Chen LH; Wang YF; Xu QH; Chen SS
    Clin Nutr; 2018 Apr; 37(2):516-521. PubMed ID: 28040302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Parker HM; Johnson NA; Burdon CA; Cohn JS; O'Connor HT; George J
    J Hepatol; 2012 Apr; 56(4):944-51. PubMed ID: 22023985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis.
    Musazadeh V; Karimi A; Malekahmadi M; Ahrabi SS; Dehghan P
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):327-334. PubMed ID: 36692292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Lu W; Li S; Li J; Wang J; Zhang R; Zhou Y; Yin Q; Zheng Y; Wang F; Xia Y; Chen K; Liu T; Lu J; Zhou Y; Guo C
    Gastroenterol Res Pract; 2016; 2016():1459790. PubMed ID: 27651787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Wang LL; Zhang PH; Yan HH
    Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
    Yan JH; Guan BJ; Gao HY; Peng XE
    Medicine (Baltimore); 2018 Sep; 97(37):e12271. PubMed ID: 30212963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
    Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
    Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Del Bo' C; Perna S; Allehdan S; Rafique A; Saad S; AlGhareeb F; Rondanelli M; Tayyem RF; Marino M; Martini D; Riso P
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis.
    Vogli S; Naska A; Marinos G; Kasdagli MI; Orfanos P
    Nutrients; 2023 Aug; 15(17):. PubMed ID: 37686767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Dong Y; Lv Q; Li S; Wu Y; Li L; Li J; Zhang F; Sun X; Tong N
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):284-295. PubMed ID: 28065744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
    Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
    J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis.
    Musazadeh V; Roshanravan N; Dehghan P; Ahrabi SS
    Front Nutr; 2022; 9():844242. PubMed ID: 35677540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis.
    Dionysopoulos G; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis N; Karanika E; Tsekitsidi E; Chourdakis M
    Crit Rev Food Sci Nutr; 2023; 63(27):8545-8553. PubMed ID: 35400251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.